Company Filing History:
Years Active: 2021
Title: Gilbert Lassalle: Innovator in Cancer Therapy
Introduction
Gilbert Lassalle is a notable inventor based in Hamburg, Germany. He has made significant contributions to the field of cancer therapy through his innovative research and inventions. With a total of two patents to his name, Lassalle is dedicated to advancing medical treatments.
Latest Patents
Lassalle's latest patents include "Phosphonium-ion tethered tetracycline drugs for treatment of cancer" and "Triphenylphosphonium-tethered tetracyclines for use in treating cancer." Both inventions focus on compounds that are useful as cancer therapies. These compounds comprise derivatives of tetracycline antibiotics, such as doxycycline, which have a phosphonium cation tethered to the tetracycline tetracycle. The inventions also relate to methods of using these compounds and to pharmaceutical formulations that include them.
Career Highlights
Gilbert Lassalle works at Oxford University Innovation Limited, where he continues to develop his research in cancer therapies. His work is characterized by a commitment to improving treatment options for patients suffering from cancer.
Collaborations
Lassalle collaborates with notable colleagues, including Tim Sparey and Andrew Ratcliffe. Their combined expertise contributes to the advancement of innovative solutions in the medical field.
Conclusion
Gilbert Lassalle's contributions to cancer therapy through his patents and collaborations highlight his dedication to improving healthcare. His work exemplifies the impact of innovation in the fight against cancer.